SICGEN Antibodies Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

SICGEN Antibodies General Information

Description

Developer of polyclonal antibodies designed for cell biology research and industrial applications. The company offers goat-derived polyclonal antibodies, custom antibody production services, and a portfolio of research-use antibodies, including antibodies targeting fluorescent proteins, enabling universities, research institutes, pharmaceutical companies, biotechnology distributors, and other life science organizations to support research and product development.

Contact Information

Website
www.sicgen.pt
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Biocant Park Nucleo 04 Lote 03
  • Cantanhede, 3060-197
  • Portugal
+351 919
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Biocant Park Nucleo 04 Lote 03
  • Cantanhede, 3060-197
  • Portugal
+351 919

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SICGEN Antibodies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator Completed Generating Revenue
1. University Spin-Out 01-Jan-2008 Completed Generating Revenue
To view SICGEN Antibodies’s complete valuation and funding history, request access »

SICGEN Antibodies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SICGEN Antibodies Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Universidade de Coimbra University
Biocant Park Accelerator/Incubator Minority
To view SICGEN Antibodies’s complete investors history, request access »

SICGEN Antibodies FAQs

  • When was SICGEN Antibodies founded?

    SICGEN Antibodies was founded in 2008.

  • Where is SICGEN Antibodies headquartered?

    SICGEN Antibodies is headquartered in Cantanhede, Portugal.

  • What is the size of SICGEN Antibodies?

    SICGEN Antibodies has 4 total employees.

  • What industry is SICGEN Antibodies in?

    SICGEN Antibodies’s primary industry is Drug Discovery.

  • Is SICGEN Antibodies a private or public company?

    SICGEN Antibodies is a Private company.

  • What is SICGEN Antibodies’s current revenue?

    The current revenue for SICGEN Antibodies is .

  • Who are SICGEN Antibodies’s investors?

    Universidade de Coimbra and Biocant Park have invested in SICGEN Antibodies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process